Adicet Bio (ACET) Retained Earnings (2017 - 2026)
Adicet Bio (ACET) posted quarterly Retained Earnings of -$37000.0 for Q1 2026, up 99.99% year-over-year from -$18500.7 in Q1 2025, and up 99.99% quarter-over-quarter from -$614.7 million in Q4 2025.
Adicet Bio (ACET) Retained Earnings (2017 - 2026) Analysis & Trends
Adicet Bio's Retained Earnings history runs 10 years deep, the most recent figure standing at -$37000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.99% year-over-year to -$37000.0; the TTM figure through Mar 2026 stood at -$37000.0 (up 99.99% YoY), while the FY2025 annual figure was -$614.7 million, down 23.46% from the prior year.
- Retained Earnings for Q1 2026 stood at -$37000.0, up from -$614.7 million in the prior quarter.
- The five-year high for Retained Earnings was $121000.0 in Q3 2024, with the low at -$614.7 million in Q4 2025.
- The 5-year median for Retained Earnings is -$394.8 million (2023), against an average of -$355.0 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 8185400.0% in 2022, then surged 100.03% in 2024.
- Adicet Bio's Retained Earnings stood at -$238.1 million in 2022, then tumbled by 59.91% to -$380.8 million in 2023, then tumbled by 30.76% to -$497.9 million in 2024, then slipped by 23.46% to -$614.7 million in 2025, then surged by 99.99% to -$37000.0 in 2026.
- Business Quant data shows ACET's Retained Earnings at -$37000.0 in Q1 2026, -$614.7 million in Q4 2025, and -$584.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | -656.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -656.30 Mn |
| Mar 31, 2026 | -37,000.00 |
| Dec 31, 2025 | -614.70 Mn |
| Sep 30, 2025 | -584.18 Mn |
| Jun 30, 2025 | -557.33 Mn |
| Mar 31, 2025 | -526.11 Mn |
| Dec 31, 2024 | -497.89 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -438.69 Mn |
| Mar 31, 2024 | -408.79 Mn |
| Dec 31, 2023 | -380.77 Mn |
| Sep 30, 2023 | -351.28 Mn |
| Dec 31, 2022 | -238.11 Mn |
| Sep 30, 2022 | -208.24 Mn |
| Mar 31, 2022 | -163.71 Mn |
| Dec 31, 2021 | -168.32 Mn |
| Sep 30, 2021 | -152.51 Mn |
| Jun 30, 2021 | -138.50 Mn |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 24,000.00 |